Report forecast the global dermatology diagnostic devices
market to grow at a CAGR of 9.04% during the period 2016-2020.
The global dermatology diagnostic devices market is
dominated by microscopes with a market share of 34% owing to its convenience in
use. They are used in almost every skin diagnostic procedures to identify the
skin condition/ailment.
Technological improvements in the field of microscopy are
focused on enhancing the accuracy and sensitivity of the detection mechanisms.
Also, the rise in skin disorders such as melanoma, dermatitis, immune
disorders, and infections has a significant impact on the market growth. For
instance, according to Centers for Disease Control and Prevention (CDC), around
72,500 people in the US were diagnosed with melanoma skin disorder of which
30,000 were women and 42,500 were men.
The report covers the present scenario and the growth
prospects of the global dermatology diagnostic devices market for 2016-2020. To
calculate the market size, the report considers the revenue generated through
the sales of dermatology diagnostic devices.
The market is divided into the following segments based
on geography:
- Americas
- APAC
- EMEA
According to the report, emphasis on early diagnosis will be
a key driver for market growth. Early diagnosis of skin cancer improves
treatment efficacy and reduces the overall burden on society in terms of
investment in research, diagnosis, and treatment. There is a significant focus
on early diagnosis and improvement of the detection rate for skin disorders in
order to reduce healthcare treatment costs, which will drive the global
dermatology diagnostic devices market. Developing countries have to increase
their spending dramatically to provide basic health insurance coverage, develop
a primary healthcare service, and improve the availability of medications in
rural and sub-urban areas. This is expected to result in the reformation of
public hospitals and healthcare facilities, thereby propelling the growth of
the global dermatology diagnostic devices market.
Further, the report states that one of the major challenges
for the market will be stringent regulatory environment. The regulatory
requirements for diagnostic devices worldwide are specific and regulatory
bodies ask for the provision of in-depth technical information, as most of them
are classified as class III medical devices. The waiting period for regulatory
approvals is long, especially in the US, which can increase developmental
expenses and delay return on investment. In Europe, the 98/79/EC of October 27
Directive is enforced on all medical in-vitro diagnostic (IVD) devices. Canada
issues a license for medical products based on their category. This license is
issued by the Health Canada authorities and the time taken to issue this
license again depends on the category of the product. These licenses are
subjected to annual renewal. Multinational vendors have to comply with various
stringent regulatory conditions of each country, which affects their
turn-around time, capital expenditure, and profitability. Thus, stringent
regulations and delays in approval process hamper the growth of the market.
Global Dermatology Diagnostic Devices Market 2016-2020,
has been prepared based on an in-depth market analysis with inputs from
industry experts. The report covers the market landscape and its growth
prospects over the coming years. The report also includes a discussion of the
key vendors operating in this market.
key players in the global dermatology diagnostic devices
market: Abbott Diagnostics, Heine Optotechnik, Michelson Diagnostics, Roche
Diagnostics, STRATA Skin Sciences, and Welch Allyn.
Other Prominent Vendors in the market are: AGFA Healthcare,
Bayer, Bio-Therapeutic, Bomtech, Bruker, Caliber Imaging & Diagnostics,
CANFIELD Imaging Systems, Carl Zeiss, DermaSpectra, Dermlite, Dermsa,
Dino-Lite, Firefly, FotoFinder Systems, GE Healthcare, KaWe Germany, Keyence
Microscope, Leica Microsystems GmbH, Medisun, MedX Health, Nikon, Olympus, Olympus,
OptikaMicroscope, Optomed, Philips, Photomedex, Pixience, Quanticare, Rudolf
Riester, SciBase, Siemens, Toshiba Medical Systems, Verisante Technology, and
ViseoMed.
Market driver
- Increase in demand for advanced dermatology diagnostic services
- For a full, detailed list, view our report
Market challenge
- Lack of accurate diagnosis and shortage of skilled technicians
- For a full, detailed list, view our report
Market trend
- Growing importance of dermatology in cosmetic industry
- For a full, detailed list, view our report
Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Spanning over 85 pages “Global Dermatology
Diagnostic Devices Market 2016 - 2020” report covers Executive summary, Scope of the
report, Market research methodology, Introduction, Market landscape, Dermatology
diagnosis: An overview, Market segmentation by product type, Global dermatology
imaging devices market, Global dermatology microscopes market, Global
dermatology immunoassays market, Global dermatology molecular diagnostics
market, Geographical segmentation, Market drivers, Impact of drivers, Market
challenges, Impact of drivers and challenges, Market trends, Vendor landscape,
Key vendor analysis, Appendix.
For
more information Visit at: http://mrr.cm/3xn
Related Reports;
Global Leukemia Therapeutics Market 2016-2020 - Visit at - http://mrr.cm/3xh
Global Multi-Parameter Patient Monitoring Equipment Market
2016-2020 - Visit at - http://mrr.cm/3x7
Global Central Nervous System Disorders Therapeutics Market
2016-2020 - Visit at - http://mrr.cm/3x8
No comments:
Post a Comment
Note: only a member of this blog may post a comment.